Rephonic
Artwork for Rx for Biotech
Clinical Trials
Gene Therapy
Cell Therapy
Healthcare
Advanced Therapies
Biotechnology
Artificial Intelligence
Multiple Myeloma
Cancer Research
Mental Health
Glioblastoma
Melanoma
Car-T Therapy
Generative AI
Health Equity
FDA
Patient Access
Pancreatic Cancer
Cystic Fibrosis
CAR T Cells

The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the healthcare ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts who are developing advanced therapies and AI-powered health technologies including physicians, healthcare providers, patient advocates, and technology leaders. To learn mo... more

PublishesTwice monthlyEpisodes87Founded6 years ago
Number of ListenersCategory
Business

Listen to this Podcast

Artwork for Rx for Biotech

Latest Episodes

What if AI could help women better understand their bodies and take control of their health before problems become crises? In this episode of #RxforBiotech, host Chris Leidli sits down with Kirsten Karchmer, Founder and CEO of Conceivable, to discuss... more

YouTube

What if the future of multiple sclerosis treatment could go beyond suppressing inflammation - and actually help protect the brain? In this episode of Rx for Biotech, host Chris Leidli sits down with Jason Tardio, President & COO of Immunic Therapeuti... more

YouTube

What if your own immune cells could be engineered to fight and even cure cancer? In this episode of Rx for Biotech, host Chris Leidli sits down with Navneet Majhail, MD, a leading expert in blood cancers, bone marrow transplants, and CAR-T cell thera... more

YouTube

Why is brain cancer so hard to detect and treat - and what if we could change that? In this episode of Rx for Biotech, host Chris Leidli sits down with Marc Hedrick, CEO of Plus Therapeutics, and Russell Bradley, General Manager of CNSide Diagnostics... more

YouTube

What if you could get a Transplant and Reset your Immune System in less than 48 Hours? In this episode of Rx for Biotech, host Chris Leidli sits down with Kevin Caldwell, CEO of Ossium Health, to explore how bone marrow transplants, cell therapy, and... more

YouTube

What if chemotherapy could target tumors without harming the rest of the body? In this episode of *Rx for Biotech*, host Chris Leidli sits down with Christina Coughlin, MD, PhD, CEO of Avacta Therapeutics, to explore a new approach to cancer treatmen... more

YouTube

What if a simple blood test could reveal how your body responds to disease - or even help doctors choose the right treatment for you? In this episode of Rx for Biotech, host Chris Leidli speaks with Mo Jain, MD, PhD, co-founder of Sapient, about how ... more

YouTube

In this episode of "Rx for Biotech", host Chris Leidli speaks with Rodney Gillespie, Senior Vice President and U.S. Therapeutic Area Head for Oncology at Novartis, about the rapid evolution of prostate cancer care, including the rise of radioligand t... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Jason Tardio
Leader at Immunic Therapeutics, focused on MS therapies
Immunic Therapeutics
Episode: The Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic
Navneet Majhail
Physician and Chief of Blood Cancers at the Serocannon Cancer Network, part of HCA Healthcare
Serocannon Cancer Network / HCA Healthcare
Episode: What If Your Own Cells Could Cure Cancer? CAR-T Therapy Explained
Marc Hedrick
President and CEO of Plus Therapeutics
Plus Therapeutics
Episode: The Future of Brain Cancer Care: Combining Diagnostics and Targeted Radiation Therapy
Russell Bradley
President and General Manager of the CNSide division
Plus Therapeutics
Episode: The Future of Brain Cancer Care: Combining Diagnostics and Targeted Radiation Therapy
Kevin Ossium
CEO of Ossium Health
Ossium Health
Episode: How Ossium Health is Changing Stem Cell Therapy and Regenerative Medicine
Chris Coughlin
Executive/leader involved in Avacta Therapeutics, with background in Immunocore and oncology therapeutics
Avacta Therapeutics
Episode: How Targeted Chemotherapy and Immunotherapy are Changing Cancer Care
Arun Swaminathan
CEO of Coya Therapeutics
Coya Therapeutics
Episode: Fixing the Body's Shield: A New Way to Fight Neurodegenerative Diseases
Nainesh Parikh
Vice President and Chief Clinical Expansion and Partnerships Officer, Moffitt Cancer Center
Moffitt Cancer Center
Episode: How to Advocate for Yourself in Cancer Care: Insights from a Top Oncologist
Øystein Rekdal
CEO of Lytix Biopharma
Lytix Biopharma
Episode: A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy

Host

Chris Leidli
Host of the Rx for Biotech podcast; appears across multiple episodes providing leadership commentary and interview facilitation.

Top Business Podcasts

The Ramsey Show
The Ramsey ShowRamsey Network
Proven Podcast
Proven PodcastCharles Schwartz
Young and Profiting with Hala Taha
Young and Profiting with Hala TahaHala Taha | Entrepreneurship, Sales, Marketing | YAP Media Network

Talking Points

Recent interactions between the hosts and their guests.

The Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic
Q: Where could Vita-Fluorimus Calcium fit in the current treatment landscape for MS?
It could fit across several stages, from newly diagnosed to older patients, and is positioned as an immunomodulator suitable for long-term use, potentially complementing or succeeding existing disease-modifying therapies.
The Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic
Q: Could you explain what makes MS difficult to treat and how Vita-Fluorimus Calcium might change that?
MS is highly heterogeneous and involves a complex immune attack that affects both inflammation and neurodegeneration; Vita-Fluorimus Calcium aims to address both processes with a dual mechanism, potentially slowing progression while maintaining safety and convenience as an oral therapy.
Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer
Q: Can you walk us through the key results from the phase 2 metastatic pancreatic cancer study and what they mean for patients?
The study showed a three-month increase in median overall survival when adding ELRA to gemabraxine, and there was a higher one-year survival rate with a durable benefit extending to 18-24 months in follow-up data, indicating a meaningful survival advantage with manageable safety signals.
How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
Q: Is your direct-to-patient offering available globally, or only in the UK/Europe for now?
The direct-to-patient offering is launching globally soon, with the capability to receive samples from anywhere with a postal service, making access worldwide possible.
How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
Q: What are your plans to expand access across Europe and into the US?
We already supply to about 40 countries and plan to showcase real-world NHS data first, then expand to other jurisdictions and the US within a couple of years, while maintaining a direct-to-patient option.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Rx for Biotech

What is Rx for Biotech about and what kind of topics does it cover?

This program centers on the frontier of advanced therapies, with conversations that thread through immunotherapy, cell and gene therapy, radiopharmaceuticals, and precision medicine. Episodes typically feature biotech C-suite leaders, physician-scientists, and industry strategists who unpack how novel treatments are discovered, manufactured, and brought to patients—covering everything from CAR-T and checkpoint biology to off-the-shelf cell products, targeted radiotherapies, and AI-enabled biomarkers. Expect practical discussions on manufacturing bottlenecks, regulatory and payer hurdles, and pathways to broader access, often paired with real-world patient implications and partnerships that aim to accelerate delivery of life-saving therapies... more

Where can I find podcast stats for Rx for Biotech?

Rephonic provides a wide range of podcast stats for Rx for Biotech. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Rx for Biotech and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Rx for Biotech get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Rx for Biotech, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Rx for Biotech?

Rephonic provides comprehensive predictive audience data for Rx for Biotech, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Rx for Biotech have?

To see how many followers or subscribers Rx for Biotech has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Rx for Biotech?

These podcasts share a similar audience with Rx for Biotech:

1. Beyond Biotech - the podcast from Labiotech
2. Biotech Hangout
3. BioCentury This Week
4. The BioCentury Show
5. The Readout Loud

How many episodes of Rx for Biotech are there?

Rx for Biotech launched 6 years ago and published 87 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Rx for Biotech?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Rx for Biotech?

Rephonic pulls ratings and reviews for Rx for Biotech from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Rx for Biotech?

Rephonic provides full transcripts for episodes of Rx for Biotech. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Rx for Biotech?

Recent guests on Rx for Biotech include:

1. Jason Tardio
2. Navneet Majhail
3. Marc Hedrick
4. Russell Bradley
5. Kevin Ossium
6. Chris Coughlin
7. Arun Swaminathan
8. Nainesh Parikh

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days